Adrian Grzybowski

Reprogramming immunomodulation using AI

Role
Chief Science Officer, Co-founder at AnuBio
Location
Memphis, TN, US
LinkedIn followers
500 followers

About Adrian Grzybowski

I am the CSO and co-founder of AnuBio, an AI-driven drug discovery company specializing in immuno-oncology. Before becoming an entrepreneur, I was a founding scientist of Alamar Biosciences (alamarbio.com), where I co-invented the most sensitive protein assay on the market, this technology facilitated their fundraising of $250M. My work in chelating recombinant antibodies discovery provided insights into the mechanism of action of biparatopic antibodies and enabled the foundation of the spin-off company Attovia (attovia.com), this technology contributed to Attovia raising $165M. At Triplebar (triplebar.com), I conceptualized and built the first-ever unbiased, ultra-high-throughput (>100M) phenotypic screening platform for immuno-oncology.My inventions in the field of epigenetic multiomics have transformed how we understand and interpret the role of histone post-translational modifications, including redefining the role of H3K4me3/H3K27me3 bivalency, which has affected over 600 previously published papers on the topic. Additionally, my inventions in the field of antibody specificity correction represent foundational technology behind companies like Nautilus Bio (NAUT:NASDAQ, Market cap ~$300M), by enabling the use of antibody off-specificity to quantify biomarkers.Contact me by email: g••••••••@gmail.comor call:+17•••••••59\"Veritas temporis filia - Truth, the daughter of time\"

Experience

  1. Chief Science Officer, Co-founder

    AnuBio

    Mar 2024 — Present · Berkeley, CA, US

    Reprogramming immunomodulation using AI • Supervised development of the world’s first multicellular scRNA-seq perturbation AI model of the immune system. • Lead in silico phenotypic drug discovery for immunomodulation of tumor microenvironment.

Education

  • University of Chicago

    Doctor of Philosophy (PhD), Cellular and Molecular Biology

    2011 — 2018

  • Jagiellonian University

    Bachelor of Science - BS, Biotechnology

    2006 — 2009

  • Jagiellonian University

    Master of Science - MS, Biotechnology

    2009 — 2011

Skills

  • Molecular Biology
  • Western Blotting
  • Shell Scripting
  • Patent Preparation
  • Sbir
  • Adobe Creative Suite
  • University Teaching
  • Project Management
  • Protein Chemistry
  • Protein Engineering
  • Grant Writing
  • Chromatography
  • Cell Biology
  • Cell Culture
  • Bioinformatics
  • Qpcr
  • Chip-Seq
  • Life Sciences
  • Antibodies
  • Biochemistry
  • Big Data
  • Chromatin Immunoprecipitation
  • Higher Education
  • Real-Time Polymerase Chain Reaction (Qpcr)
  • Pcr
  • Dna Sequencing
  • R
  • Tissue Culture
  • Ddpcr
  • Linux
  • Biotechnology
  • Protein Purification
  • Epigenetics
  • Crispr
  • Rnaseq
  • Data
  • Quantitative Research
  • Molecular Cloning
  • Transfection
  • Microsoft Office

Find verified contacts for anyone on LinkedIn

Unifers gives sales teams verified emails and direct dials, enriched profiles, and outreach that lands in the inbox.

Free plan included · No credit card required

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.

Adrian Grzybowski — Chief Science Officer, Co-founder at AnuBio in Memphis, TN, US | Unifers